Skip to main content

Table 3 Chemotherapy dose modifications and delays

From: Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study

 

Cycles (n = 256)

Patients (n = 50)

Methotrexate dose modification

35

13.7%

14

28%

BCNU dose modification

38

14.8%

14

28%

Any dose modification

55

21.5%

18

36%

Cycle delay

22

8.6%

10

20%